Abraxane, a cancer chemotherapy made by Celgene, slowed tumor growth and cut the risk of death in patients with advanced pancreatic cancer, according to results that will be presented at a conference on gastrointestinal tumors being held by the American Society of Clinical Oncology.
FORBES: Celgene's Abraxane Extends Life By 1.8 Months In Advanced Pancreatic Cancer